Target Cancer | From Dogs to Humans: The Power of Precision Medicine with Dr. Lim | TCP Ep. 70 @TargetCancer | Uploaded September 2024 | Updated October 2024, 8 hours ago.
From Dogs to Humans: The Power of Precision Medicine with Dr. Lim | TARGET: Cancer Podcast | Ep. 70
Dr. Lim takes us through the evolution of personalized cancer therapy, starting from animal trials and advancing to human treatments. He explains how artificial intelligence is playing a critical role in creating precise and effective treatment plans in oncology. Explore the impact of AI in transforming cancer care by offering more personalized therapies, and how precision medicine is shaping the future of patient outcomes.
- - - -TimeStamps - - - -
00:00 - Introduction
02:54 - Combination Chemotherapy and Its Challenges
09:05 - Transition to Veterinary Oncology
18:39 - Preserving Tumor Microenvironment
27:10 - Predicting Treatment Outcomes
33:46 - Evaluating Treatment Responses and Toxicity
43:26 - The Role of Machine Learning in Cancer Treatment
- - - -
#cancertreatment #precisionmedicine #animalhealth #medicaltechnology
đź”´Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. SUNGWON LIM —
Dr. Sungwon Lim is the CEO and Co-Founder of ImpriMed, Inc., a pioneering company that leverages artificial intelligence to analyze live cancer cells and predict patient responses to cancer therapies before treatment. With a PhD in Bioengineering from Stanford University and a master’s degree in Translational Medicine from the UC Berkeley–UCSF Joint Bioengineering Program, Dr. Lim brings over 20 years of experience in both academia and the biotech industry. His work primarily focuses on the development of novel cancer therapies, and he is a passionate advocate for functional precision medicine, which tailors cancer treatments based on the functional responses of individual patients' cancer cells to various drugs, rather than solely relying on genetic information. As a bioengineer and entrepreneur, Dr. Lim is dedicated to advancing personalized cancer care through innovative approaches that integrate technology and medicine.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Learn more at: xcures.com
Facebook: facebook.com/xcures.platform
TikTok: tiktok.com/@xcures.platform
Instagram: instagram.com/xcures.platform
LinkedIn: linkedin.com/company/xcures
Twitter: twitter.com/xcures_platform
TARGET: Cancer Podcast
Homepage: xcures.com/target-cancer-podcast
YouTube: youtube.com/TargetCancer
Spotify: open.spotify.com/show/2xMG5y5gOoIut5Ykvm63XO?si=0b478259417f40f4
iTunes: podcasts.apple.com/us/podcast/target-cancer-podcast/id1593087681
TuneIn:
tunein.com/podcasts/Technology-Podcasts/Target-Cancer-Podcast-p1761270/?topicId=176003304
YouTube Music:
music.youtube.com/playlist?list=PLLCMfi_7jfhTEwW2OmeUGTcy3_jFD_IOD&si=-XNfbSz-uhrW2VyI
Pandora:
pandora.com/podcast/target-cancer-podcast/PC:1001022571
Amazon Music:
music.amazon.com/podcasts/a8011808-57b8-42b3-a6df-abe02bb9011d
From Dogs to Humans: The Power of Precision Medicine with Dr. Lim | TARGET: Cancer Podcast | Ep. 70
Dr. Lim takes us through the evolution of personalized cancer therapy, starting from animal trials and advancing to human treatments. He explains how artificial intelligence is playing a critical role in creating precise and effective treatment plans in oncology. Explore the impact of AI in transforming cancer care by offering more personalized therapies, and how precision medicine is shaping the future of patient outcomes.
- - - -TimeStamps - - - -
00:00 - Introduction
02:54 - Combination Chemotherapy and Its Challenges
09:05 - Transition to Veterinary Oncology
18:39 - Preserving Tumor Microenvironment
27:10 - Predicting Treatment Outcomes
33:46 - Evaluating Treatment Responses and Toxicity
43:26 - The Role of Machine Learning in Cancer Treatment
- - - -
#cancertreatment #precisionmedicine #animalhealth #medicaltechnology
đź”´Like, Subscribe, and Share to see more of this type of content!
— ABOUT DR. SUNGWON LIM —
Dr. Sungwon Lim is the CEO and Co-Founder of ImpriMed, Inc., a pioneering company that leverages artificial intelligence to analyze live cancer cells and predict patient responses to cancer therapies before treatment. With a PhD in Bioengineering from Stanford University and a master’s degree in Translational Medicine from the UC Berkeley–UCSF Joint Bioengineering Program, Dr. Lim brings over 20 years of experience in both academia and the biotech industry. His work primarily focuses on the development of novel cancer therapies, and he is a passionate advocate for functional precision medicine, which tailors cancer treatments based on the functional responses of individual patients' cancer cells to various drugs, rather than solely relying on genetic information. As a bioengineer and entrepreneur, Dr. Lim is dedicated to advancing personalized cancer care through innovative approaches that integrate technology and medicine.
— ABOUT DR. SANJAY JUNEJA —
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
— ABOUT xCURES —
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Learn more at: xcures.com
Facebook: facebook.com/xcures.platform
TikTok: tiktok.com/@xcures.platform
Instagram: instagram.com/xcures.platform
LinkedIn: linkedin.com/company/xcures
Twitter: twitter.com/xcures_platform
TARGET: Cancer Podcast
Homepage: xcures.com/target-cancer-podcast
YouTube: youtube.com/TargetCancer
Spotify: open.spotify.com/show/2xMG5y5gOoIut5Ykvm63XO?si=0b478259417f40f4
iTunes: podcasts.apple.com/us/podcast/target-cancer-podcast/id1593087681
TuneIn:
tunein.com/podcasts/Technology-Podcasts/Target-Cancer-Podcast-p1761270/?topicId=176003304
YouTube Music:
music.youtube.com/playlist?list=PLLCMfi_7jfhTEwW2OmeUGTcy3_jFD_IOD&si=-XNfbSz-uhrW2VyI
Pandora:
pandora.com/podcast/target-cancer-podcast/PC:1001022571
Amazon Music:
music.amazon.com/podcasts/a8011808-57b8-42b3-a6df-abe02bb9011d
